The Boston Consulting Group (BCG) and Munich Reinsurance jointly released a report on the 24th of the coming of "Commercial health insurance, and insurance companies must build six capabilities", pointing out that the middle class and the wealthy are actively seeking alternatives to public health insurance, by 2020. The scale of China's commercial medical insurance market will increase nearly fourfold, from RMB 241 billion in 2015 to RMB 1.1 trillion. The report believes that changing consumer demand and government incentives and support for private health care providers are the driving force behind this growth. The report predicts that reimbursement medical insurance is expected to become the fastest growing category in the market. Compared with the major illness insurance that many Chinese consumers currently purchase, such insurance products have higher premiums (especially high-end products), but the flexibility is relatively stronger. If the insured person of the major illness insurance is diagnosed as pre-agreed to cover the disease, he will receive a one-time compensation; the reimbursement medical insurance can be used when the insured person is sick and needs multiple medical consultations. Provide reimbursement for ongoing health care costs. Luo Ying, one of the authors of the report and a partner of the BCG Beijing office, said: "The Chinese market has created ideal conditions for the development of reimbursable commercial medical insurance. Due to the high cost, such products have not yet been popularized, but many people have a strong interest in it. Therefore, we expect new products in related fields to emerge in the next few years." The Chinese consumer survey reveals that insurance companies are facing valuable development opportunities: the current potential customers who are most likely to purchase reimbursement medical insurance are those aged 35 to 55, married and have a family income of more than 200,000 yuan. By. By 2020, such people across China are expected to exceed 40 million; the wealthiest of them are willing to pay 30,000 to 60,000 yuan a year for a family of three to buy reimbursement commercial medical insurance. The report expects that the profitability of reimbursement commercial medical insurance will continue to increase, in part due to favorable policies that support the development of commercial health insurance and private medical institutions, such as the purchase of commercial health insurance can enjoy personal income tax benefits. Driven by demand growth and policy incentives, the total number of private hospitals in China has quadrupled, from 3,200 in 2005 to the current 12,500. The report predicts that by 2020, the size of the reimbursement-type medical insurance market is expected to increase to 400 billion yuan, accounting for 36% of the Chinese commercial health insurance market with an overall size of 1.1 trillion yuan. The remaining 64% are major illness insurance led by life insurance companies; this market category is growing at a relatively low rate. Radish / Turnip Jiangsu Tiankang Food Co., Ltd. , https://www.tiankangfood.com